Strata Critical Medical (SRTA) Equity Ratio (2019 - 2026)

Strata Critical Medical has disclosed Equity Ratio across 8 years of filings, most recently posting 0.87 for Q1 2026.

• In Q1 2026, Equity Ratio fell 0.55% year-over-year to 0.87; the TTM figure through Mar 2026 stood at 0.87 (down 0.55% YoY), while the FY2025 annual figure was 0.86, down 0.84% from the prior year.
• Equity Ratio improved to 0.87 in Q1 2026, from 0.86 in the prior quarter.
• Over the last five years, Equity Ratio for SRTA reached as high as 0.9 in Q2 2022 and fell as low as 0.79 in Q4 2023.
• The 5-year median for Equity Ratio is 0.84 (2025), against an average of 0.85.
• Annual changes were most pronounced in 2022 — Equity Ratio soared 3021.33% — and 2023, when it decreased 9.67%.
• A 5-year view of Equity Ratio shows it stood at 0.84 in 2022, then fell by 5.93% to 0.79 in 2023, then climbed by 8.84% to 0.86 in 2024, then decreased by 0.84% to 0.86 in 2025, then increased by 1.72% to 0.87 in 2026.
• According to Business Quant data, Equity Ratio over the past three periods registered 0.87, 0.86, and 0.84 for Q1 2026, Q4 2025, and Q3 2025 respectively.